3. Fatigue
4. Dental pain
5. Cough
6. Ear pain/pressure/fullness
• Diagnosis requires two major symptoms, or one major and two minor symptoms; secondary criteria only “count” if accompanied by another major criterion.
• Purulent nasal secretions on exam confirms the diagnosis.
Clinical Practice Guidelines on Adult Rhinosinusitis (2015)
• Revised to simplify diagnosis
• Symptoms for 4 weeks or less
• Purulent nasal drainage (anterior, posterior, or both) accompanied by nasal obstruction, facial pain-pressure-fullness, or both
• Viral rhinosinusitis: symptoms/signs of ARS fewer than 10 days; symptoms not worsening
• Acute bacterial rhinosinusitis (ABRS): symptom/signs of ARS for 10 days or more, or double worsening (worsen within 10 days after initial improvement)
• Purulent nasal secretions on exam
• Transillumination not useful
• Diagnosis is clinical
• Imaging not indicated unless complication suspected
Canadian Rhinosinusitis Guidelines (2011)
• Table 10–1 contains the guidelines.
Diagnosis of Chronic Rhinosinusitis
Task Force on Rhinosinusitis of AAO-HNS (1997)
• Symptoms for 3 months or longer
• Two of the following major criteria are required:
1. Nasal obstruction/congestion
2. Thick rhinorrhea or post-nasal purulent discharge
3. Facial pain/pressure
4. Decreased sense of smell (hyposmia)
• Seven minor criteria:
1. Headache
2. Halitosis
3. Fever
TABLE 10–1. ABRS Diagnosis Requires the Presence of At Least Two Major Symptoms*
* For diagnosis of ABRS, patient must have: (1) nasal obstruction OR nasal purulence/discolored postnasal discharge, AND (2) at least one other PODS symptom.
5. Dental pain
6. Cough
7. Ear pain/pressure/fullness
• Diagnosis requires two major symptoms, or one major and two minor symptoms
• Also requires one finding that confirms inflammation: mucosal thickening on CT scan; nasal polyps on rhinoscopy; or polyps, purulence, or edema on nasal endoscopy
Clinical Practice Guidelines on Adult Rhinosinusitis (2015)
• Revised to simplify diagnosis
• Twelve weeks or longer of two or more signs/symptoms:
1. Mucopurulent drainage (anterior, posterior, or both)
2. Nasal obstruction/congestion
3. Facial pain-pressure-fullness
4. Decreased sense of smell
• AND inflammation is documented by one or more findings:
1. Purulent (not clear) mucus or edema in middle meatus or anterior ethmoid region
2. Polyps in nasal cavity or middle meatus
3. Radiographic imaging showing sinus inflammation
• Need to confirm presence or absence of polyps
European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS 2012)
• Defined as inflammation in the nose and paranasal sinuses
Definition in Adults
• Two or more symptoms, one being either nasal blockage/congestion or nasal discharge (anterior/posterior), +/− facial pain or pressure, +/− reduction or loss of smell
• And either:
1. Endoscopic signs of nasal polyps, mucopurulent discharge primarily from middle meatus, or edema/mucosal obstruction primarily in middle meatus
2. CT showing mucosal changes within the OMC and/or sinuses
• Subdivided into CRS with polyps (CRSwNP) and without polyps (CRSsNP)
• CRSwNP: bilateral endoscopically visualized polyps in middle meatus
• CRSsNP: no visible polyps in middle meatus (if necessary following decongestant)
Definition in Children
• Substitutes +/− cough instead of +/− reduction or loss of smell
• Otherwise criteria are the same
Canadian Rhinosinusitis Guidelines (2011)
• Table 10–2 shows the guidelines.
Classification of Rhinosinusitis
Chronic Rhinosinusitis
• Multiple proposals
Phenotype Based on Asthma and Atopy Status
(Han JK, Laryngoscope. 2013;Mar;123 Suppl2:S15–27)
• Non-asthmatic CRS w/o allergy: purulence, low CT score, no polyps, Th1 profile, PMNs, IL-6, IL-8
• Non-asthmatic CRS with allergy: small polyps, less purulence, moderate CT score, eosinophils/mast cells, interferon-gamma
• Asthmatic CRS with allergy: large polyps, no purulence, high CT score, severe atopy, Th2 profile, IL-5, eos; “unified airway disease”
• Asthmatic CRS w/o allergy: large polyps, no purulence, high CT score, adult-onset asthma, minimal atopy, Th2 profile, eos; possible AERD precursor
• Aspirin-exacerbated respiratory disease (AERD): abundant polyps, no purulence, high CT score, adult-onset asthma, NSAID-induced bronchospasm, IL-4, eos, urine LTE4
• Allergic fungal sinusitis (AFS): may be unilateral, large polyps, some purulence, allergic mucin, high CT score, IL-5, IgE
Emerging Classification Schemes
• Phenotyping by other clinical data: age, lost productivity, patient-reported symptom scores
• Endotyping according to cellular and molecular biomarkers
• Microbiome composition, diversity, growth patterns
• Genotyping of receptors, factors of innate immunity
Table 10–2. CRS Diagnosis Requires the Presence of At Least Two Major Symptoms*
* A diagnosis requires at least two CPODS, present for 8 to 12 weeks, plus documented inflammation of the paranasal sinuses or nasal mucosa.